Every Form 4 that Babcock & Wilcox Enterprises, Inc. 8.125% Senior Notes due 2026 (BWSN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BWSN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BWSN filings page.
Babcock & Wilcox Enterprises General Counsel & Secretary John J. Dziewisz reported compensation-related equity activity in company stock. On May 29, 2026, he exercised derivative awards to acquire a total of 218,334 shares of common stock and had 96,285 shares withheld to cover tax obligations, according to the filing’s F-coded transactions. He also received a grant of 50,000 restricted stock units under the company’s Amended and Restated Long-Term 2021 Incentive Plan, while several previously granted RSUs were accelerated to vest on that same date. The transactions reflect option and RSU exercises with associated tax withholding rather than any open-market purchases or sales.
Babcock & Wilcox Enterprises director Naomi Louise Boness reported compensation-related equity activity involving restricted stock units and common stock. On May 15, 2026, she exercised or converted derivative securities into 85,000 shares of common stock and received a new grant of 8,725 restricted stock units under the company’s Amended and Restated 2021 Long-Term Incentive Plan.
A portion of the vested restricted stock units representing 46,750 shares was settled in cash by the company to facilitate her tax payments, classified as a disposition to the issuer. Following these transactions, she directly owned 189,530 shares of common stock. The new restricted stock units are scheduled to vest on May 15, 2026 and May 15, 2027, or on the date of the next annual meeting in each case, whichever is earlier.
Babcock & Wilcox Enterprises, Inc. director Rebecca L. Stahl reported compensation-related equity moves. She exercised 85,000 restricted stock units into common stock and the company settled 46,750 common shares with her at $21.22 per share to facilitate tax payments. After these transactions she directly holds 184,013 common shares and 8,725 restricted stock units, with the new units vesting on May 15, 2027 or the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Alan B. Howe reported several equity compensation-related transactions in company stock. On May 15, 2026, he exercised 85,000 Restricted Stock Units, which converted into an equal number of common shares at a stated value of $21.22 per share. The filing notes that a portion of the vested restricted stock units was settled in cash by Babcock & Wilcox to facilitate his tax payments, rather than through open-market sales.
Following these transactions, Howe held 165,994 shares of common stock directly, in addition to indirect holdings of 72,606 shares through the Alan & Penny Howe Trust, where he serves as trustee, and 13,000 shares in an IRA. He also received a new grant of 8,725 Restricted Stock Units under the company’s Amended and Restated 2021 Long-Term Incentive Plan, representing a contingent right to receive common stock, with vesting tied to future dates or the next annual meeting.
Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity. On May 15, 2026, she exercised 3,021 shares of common stock at $21.22 per share from restricted stock units and held 53,021 common shares afterward.
She also received 8,725 new restricted stock units tied to common stock, which vest on May 15, 2027 or the next annual meeting, and previously received 3,021 restricted stock units that vest on May 15, 2026. After these grants, she directly holds both common shares and unvested restricted stock units.
Babcock & Wilcox Enterprises director Philip D. Moeller reported compensation-related share activity involving restricted stock units. He exercised or converted 85,000 restricted stock units into common stock, and 46,750 shares were settled in cash by the company to cover tax payments under the award terms. After these transactions, he directly held 235,809 shares of common stock. Moeller also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, which are scheduled to vest on May 15, 2027 or on the date of the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Joseph A. Tato reported compensation-related equity activity. On May 15, 2026, he exercised 85,000 restricted stock units into common stock at a reported value of $21.22 per share. To facilitate tax payments, 46,750 shares were settled back to the company in cash under the award terms, rather than sold on the open market. Following these transactions, he directly held 207,338 common shares. He also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, each representing one share of common stock, vesting by May 15, 2027 or the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises Chief Financial Officer Cameron M. Frymyer acquired additional equity through compensation and a small market purchase. On March 16, 2026, Frymyer received and immediately vested in 225,000 restricted stock units, which converted into the same number of common shares. The company withheld 100,350 shares at $10.51 per share to cover tax obligations, leaving the remaining shares as new holdings. On March 18, 2026, Frymyer made an open‑market purchase of 1,285 common shares at $14.76 per share. Following these transactions, Frymyer directly owned 324,143 common shares, with no remaining RSU derivative position reported.
Babcock & Wilcox Enterprises CEO Kenneth M. Young reported several equity transactions. On March 18, 2026, he bought 7,000 shares of common stock in an open‑market purchase at a weighted average price of $15.145 per share, bringing his direct holdings to 1,656,512 shares.
On March 16, 2026, he received 250,000 restricted stock units under the company’s long‑term 2021 incentive plan, which vested immediately and were converted into 250,000 common shares. To pay related tax withholding obligations, 119,625 shares of common stock were withheld. The filing also shows 272,767 shares of common stock held indirectly through the Kenneth M. Young Revocable Trust U/A 5/8/15.
Babcock & Wilcox Enterprises General Counsel & Secretary John J. Dziewisz received a grant of 25,000 restricted stock units (RSUs) that vested immediately and were converted into 25,000 shares of common stock at a stated value of $10.51 per share.
To cover tax withholding obligations upon vesting, 11,150 common shares were withheld by the company, leaving Dziewisz with a net increase of 13,850 common shares. Following these transactions, he holds 294,718 common shares directly and 2.25 common shares indirectly through a 401(k) plan.
Babcock & Wilcox Enterprises, Inc. Chief Executive Officer Kenneth M. Young exercised 150,000 performance stock units into common shares on March 5, 2026 at a transaction price of $13.29 per share.
To cover tax withholding obligations tied to the PSUs’ vesting, 75,150 common shares were withheld by the company. After these transactions, Young directly owned 1,519,137 common shares, and 272,767 additional shares were held indirectly through the Kenneth M. Young Revocable Trust. The PSUs were granted under the company’s Amended and Restated 2021 Long-Term Incentive Plan and vest in full if the stock reaches $12.00 per share on any trading day between July 28, 2022 and July 27, 2027.
Babcock & Wilcox Enterprises, Inc. Chief Financial Officer Cameron M. Frymyer reported equity award activity involving performance stock units and common shares. On March 5, 2026, 75,000 performance stock units were exercised into 75,000 shares of common stock at a stated price of $13.29 per share. To cover tax withholding obligations upon vesting of these units, 33,450 common shares were withheld by the company. Following these transactions, Frymyer directly owned 198,208 shares of Babcock & Wilcox common stock.
Babcock & Wilcox Enterprises General Counsel & Secretary John J. Dziewisz exercised performance stock units and received common shares. On March 5, 2026, he converted 75,000 performance stock units into 75,000 shares of common stock at a stated price of $13.29 per share.
To cover tax withholding obligations upon vesting, 33,513 common shares were withheld by the company, a non–open-market disposition. After these transactions, he directly held 280,868 common shares and indirectly held 2.25 common shares through a 401k Plan.
Babcock & Wilcox Enterprises 10% owner Bryant R. Riley reported a significant insider sale of common stock. On February 11, 2026, Riley executed an open-market sale of 1,155,382 shares of B&W common stock at $9 per share, reducing his directly held position to zero.
According to the filing, these shares were held directly by Riley and were sold to satisfy repayment of debt as described in a related Schedule 13D. The Form 4 is filed jointly with BRC Group Holdings, BRF Investments, and B. Riley Securities, which report large indirect holdings through affiliated entities and accounts.
Babcock & Wilcox Enterprises (BW) reported an insider purchase by its Chief Financial Officer. On 11/12/2025, the CFO acquired 2,853 shares of common stock at a price of $7.05 per share, coded as an open market purchase (P).
Following this transaction, the executive beneficially owned 156,658 shares, held directly. The filing lists no derivative securities activity.
Babcock & Wilcox Enterprises (BW) CEO and director Kenneth M. Young purchased company stock on 11/12/2025.
He bought 1,675 shares at a weighted average price of $7.16 (with individual trades ranging from $7.13 to $7.43) and 1,500 shares at $7.13.
Following these trades, beneficial ownership stands at 1,444,287 shares direct and 272,767 shares indirect, held by the Kenneth M. Young Revocable Trust U/A 5/8/15.